| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Csmo | Cmso | Chief Sales & Marketing Office
1 company
Glenn E Adriance last filed a Form 4 in March 2018, as Csmo at MLAB. Glenn E Adriance's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 10,000 shares of MLAB. The MLAB filings lean toward selling, a net 18,637 shares.
Glenn E Adriance has 9 Form 4 filings on record from February 2015 to March 2018, all as Csmo at Mesa Laboratories (MLAB), 2015–2018.
The 16 reported transactions were 6 open-market sales, 5 option or other derivative awards, 4 option exercises and 1 other transaction.
Counted by filing, the open-market trades come to no purchases and 4 sales worth about $2.4M.
The largest open-market sale was 8,070 shares of MLAB at an average $124.15 on February 7, 2017, about $1.0M.
Shares as reported in the last Form 4 for each company; the most recent is from March 2018. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 9, 2017 | MLAB Mesa Laboratories Inc /co/ | Csmo | Sell | 4,000 | $148.98 | $595,920.00 | -28.6% | |
| Feb 7, 2017 | MLAB Mesa Laboratories Inc /co/ | Csmo | Sale+OE | 8,070 | $124.15 | $1,001,893.00 | -53.2% | |
| Nov 23, 2016 | MLAB Mesa Laboratories Inc /co/ | Cmso | Sale+OE | 3,567 | $135.93 | $484,862.31 | -20.2% | |
| Jun 6, 2016 | MLAB Mesa Laboratories Inc /co/ | Csmo | Sell | 3,000 | $111.74 | $335,220.00 | -17.5% |